Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cryo-freezing of chest nerves to reduce pain after double lung transplant

Official title: Intercostal Cryoanalgesia in Double Lung Transplant Recipients

Run by University of California, Los Angeles · NCT07281118 · Data updated 2026-11-12

This tests whether freezing the nerves around the chest incision during double lung transplant helps adults need fewer opioid pain medicines and recover faster.

More Post Operative Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment148 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations3 sites (Los Angeles, California and 2 other locations)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedNovember 24, 2027
Study endsNovember 24, 2027
Registry record updatedMarch 5, 2026
Trial IDNCT07281118 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) undergoing double lung transplantation via bilateral thoracotomies or a clamshell incision who are not receiving multi-organ or redo lung transplants.

Probably not a fit

Patients undergoing single lung transplant, multi-organ transplants, redo lung transplants, or those treated outside the participating centers are not eligible and therefore unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

During double lung transplant surgery, surgeons may use a cold-therapy probe (Atricure CryoSPHERE MAX) to gently freeze the intercostal nerves near the incision to reduce pain for several days. Patients who receive intraoperative cryoanalgesia will be compared with patients receiving usual care without the device across several hospitals, with about 148 adults expected to enroll. The main goal is to see whether the cryotherapy group uses at least 25% fewer opioids in the first 10 days after surgery, and secondary outcomes include need for additional pain treatments like epidurals, average daily pain scores, and ICU length of stay. All participants will be followed for one year to monitor recovery and any long-term effects.

Why it matters

Potential benefit: If successful, the technique could cut opioid needs after transplant, improve breathing and alertness, and potentially shorten ICU stays.

How similar studies have gone: Intercostal cryoanalgesia has shown promising reductions in pain and opioid use in other thoracic surgeries, but data are limited specifically for double lung transplant patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults ≥18 years of age
* Undergoing double lung transplantation via bilateral thoracotomies or clamshell incision

Exclusion Criteria:

* Multi-organ transplant recipients
* Redo lung transplant recipients

Where it's running

  • University of California Los Angeles
    Los Angeles, California, United States
    Recruiting
  • University of California San Francisco
    San Francisco, California, United States
    Not yet recruiting
  • Baylor University
    Waco, Texas, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.